Loading resource…

Springer-Verlag GmbH Germany, part of Springer Nature and ESICM
Anticoagulation is essential in managing thromboembolic disorders, especially in the ICU where the risks of bleeding and thrombosis are significant. The paper discusses the indications for DOACs, their pharmacokinetics, and management strategies for complications such as major bleeding. It emphasizes the need for careful consideration of DOAC use in ICU patients due to potential risks and the lack of extensive data on their safety and efficacy in this population.
No account needed